Chicago team uses artificial intelligence to diagnose metastatic cancerJuly 28, 2009When doctors are managing care for women with breast cancer, the information available to them profoundly influences the type of care they recommend. Knowing whether a woman's cancer has metastasized, for instance, directly affects how her doctors will approach treatment -- which may in turn influence the outcome of that treatment. Determining whether a tumor has metastasized is not always straightforward, however. Radiologists often start by using diagnostic ultrasound to non-invasively probe the nearby lymph nodes -- tissues where cancer cells first migrate once they metastasize. But in the early stages of cancer, lymph nodes often appear completely normal even if the cancer has metastasized. Now a team of researchers at the University of Chicago has designed a computer program that uses artificial intelligence to analyze the features of ultrasound images in order to help doctors predict earlier whether a woman's cancer has metastasized. The team will discuss the first preclinical results obtained using this program at the upcoming meeting of the American Association of Physicists in Medicine (AAPM), which takes place from July 26 - 30, 2009 in Anaheim, California. Currently there are no automated methods approved by the Food and Drug Administration for diagnosing cancer, but on Wednesday the team will report the results of a preliminary pilot study that retrospectively reanalyzed the diagnostic ultrasounds of 50 women with suspected breast cancer who all had lymph nodes that appeared normal in the ultrasound -- suggesting that their cancers had not metastasized. All 50 women later underwent surgery to remove their cancers and axillary lymph nodes, and tissue biopsies of the lymph nodes revealed that 20 of them had metastatic cancer and 30 of them had cancer that remained localized at the time of surgery. The pilot study aimed to determine if the computer would have accurately identified the 20 metastatic cases based on analyzing the ultrasound images of the tumors. The program performed promisingly well, says medical physicist Karen Drukker, a research associate and assistant professor in the department of radiology at the University of Chicago, who will be presenting results in Anaheim that demonstrate the program's potential for diagnosing metastatic disease. "We discovered that a computer analysis of breast ultrasound could potentially predict with promising accuracy which patients had metastasis and which did not," says Drukker. Next they plan to start an observer study in which several radiologists will use the computer program to see if it enhances their ability to diagnose metastasis -- again, based on retrospective cases for which the answer can later be revealed. American Institute of Physics |
|||||||||||||||||||||
| Related Metastatic Cancer Current Events and Metastatic Cancer News Articles Experimental agent reduces breast cancer metastasis to bone Researchers have reduced breast cancer metastasis to bone using an experimental agent to inhibit ROCK, a protein that was found to be over-expressed in metastatic breast cancer. Blood vessels might predict prostate cancer behavior A diagnosis of prostate cancer raises the question for patients and their physicians as to how the tumor will behave. Will it grow quickly and aggressively and require continuous treatment, or slowly, allowing therapy and its risks to be safely delayed? NEDD9 Protein Supports Growth of Aggressive Breast Cancer Researchers at Fox Chase Cancer Center have demonstrated that a protein called NEDD9 may be required for some of the most aggressive forms of breast cancer to grow. Their findings, based on the study of a mouse model of breast cancer, are presented in a recent issue of Cancer Research, available on-line now. Getting down to details Dave Wilson was dissatisfied with blurry, low-sensitivity optical images of diseased tissues. So, four years ago he set out to create a better imager. Study looks at using the immune system to reduce prostate cancer risk Immune therapies have been explored as a way to treat cancer after it develops. Protein plays unexpected role protecting chromosome tips A protein specialist that opens the genomic door for DNA repair and gene expression also turns out to be a multi-tasking workhorse that protects the tips of chromosomes and dabbles in a protein-destruction complex, a team lead by researchers at The University of Texas M. D. Anderson Cancer Center reports in the Aug. 13 edition of Molecular Cell. Predicting the return of prostate cancer: New Johns Hopkins study betters the odds of success Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis. RNA snippet suppresses spread of aggressive breast cancer A low cellular level of a tiny fragment of RNA appears to increase the spread of breast cancer in mouse models of the disease, according to researchers at Whitehead Institute for Biomedical Research. LSUHSC research describes function of key protein in cancer spread Research led by David Worthylake, PhD, Assistant Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, may help lay the groundwork for the development of a compound to prevent the spread of cancer. Autopsy Study Links Prostate Cancer to Singe Rogue Cell One cell"¦one initial set of genetic changes -- that's all it takes to begin a series of events that lead to metastatic cancer. More Metastatic Cancer Current Events and Metastatic Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||